Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen C. Glover currently holds 54,876 shares of Ambrx Biopharma, Inc. (AMAM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen C. Glover has been a net neutral trader of AMAM stock. They have purchased $0 and sold $0 worth of shares.
Stephen C. Glover's most recent insider trade was on Jan 12, 2026, when they sold 54,876 shares at $0.00 per share.
Stephen C. Glover serves as Executive at Ambrx Biopharma, Inc. (AMAM). They have executed 12 insider transactions totaling $0 over their tenure at the company.
Stephen C. Glover holds the position of Executive at Ambrx Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Stephen C. Glover has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Stephen C. Glover was on Jan 12, 2026, when they purchased $0 worth of PDSB shares. This transaction involved 54,876 shares at N/A per share.
Stephen C. Glover currently owns 54,876 shares of Ambrx Biopharma, Inc. (AMAM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen C. Glover's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen C. Glover has 12 Form 4 filings on record as an insider at Ambrx Biopharma, Inc..
Set alerts for Stephen C. Glover and 40,000+ other insiders.